EP0627930A4 - Composition et procede de traitement de l'hepatite b. - Google Patents
Composition et procede de traitement de l'hepatite b.Info
- Publication number
- EP0627930A4 EP0627930A4 EP93917072A EP93917072A EP0627930A4 EP 0627930 A4 EP0627930 A4 EP 0627930A4 EP 93917072 A EP93917072 A EP 93917072A EP 93917072 A EP93917072 A EP 93917072A EP 0627930 A4 EP0627930 A4 EP 0627930A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- treating hepatitis
- hepatitis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91467392A | 1992-07-13 | 1992-07-13 | |
US914673 | 1992-07-13 | ||
PCT/US1993/006485 WO1994001125A1 (fr) | 1992-07-13 | 1993-07-09 | Composition et procede de traitement de l'hepatite b |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0627930A1 EP0627930A1 (fr) | 1994-12-14 |
EP0627930A4 true EP0627930A4 (fr) | 1997-08-20 |
Family
ID=25434648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93917072A Withdrawn EP0627930A4 (fr) | 1992-07-13 | 1993-07-09 | Composition et procede de traitement de l'hepatite b. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0627930A4 (fr) |
CN (1) | CN1087829A (fr) |
AU (1) | AU4671193A (fr) |
MX (1) | MX9304209A (fr) |
WO (1) | WO1994001125A1 (fr) |
ZA (1) | ZA935055B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200952B1 (en) | 1993-06-02 | 2001-03-13 | Sciclone Pharmaceuticals, Inc. | Combination therapy method for treating chronic hepatitis B |
ES2194860T3 (es) * | 1993-11-05 | 2003-12-01 | Sciclone Pharmaceuticals Inc | Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada. |
US6199073B1 (en) | 1997-04-21 | 2001-03-06 | Ricoh Company, Ltd. | Automatic archiving of documents during their transfer between a peripheral device and a processing device |
US5939423A (en) * | 1997-04-16 | 1999-08-17 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
US6288033B1 (en) | 1998-09-25 | 2001-09-11 | Sciclone Pharmaceuticals, Inc. | Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
US8716012B2 (en) | 2009-05-08 | 2014-05-06 | Sciclone Pharmaceuticals, Inc. | Alpha thymosin peptides as vaccine enhancers |
US8809265B2 (en) | 2011-10-21 | 2014-08-19 | Abbvie Inc. | Methods for treating HCV |
DK2583677T1 (da) | 2011-10-21 | 2015-01-19 | Abbvie Inc | Fremgangsmåder til behandling af HCV omfattende mindst to direktevirkende antivirale midler, ribavirin, men ikke inteferon |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
CN103494769B (zh) * | 2013-10-08 | 2015-12-23 | 深圳翰宇药业股份有限公司 | 一种治疗慢性乙肝的复方长效原位凝胶注射剂及其制备方法 |
JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
CN111450240A (zh) * | 2020-04-27 | 2020-07-28 | 浙江大学 | 小分子化合物MLN4924与IFNα组合在抗HBV中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0357571A2 (fr) * | 1988-06-10 | 1990-03-07 | Medivir Aktiebolag | Pyrimidine-nucléosides |
WO1993005806A1 (fr) * | 1991-09-13 | 1993-04-01 | Alpha 1 Biomedicals, Inc. | Composition et procede pour le traitement de l'hepatite c |
WO1996000573A1 (fr) * | 1994-06-30 | 1996-01-11 | Bio-Logic Research And Development Corporation | Compositions pour stimuler la fonction immunitaire |
-
1993
- 1993-07-09 WO PCT/US1993/006485 patent/WO1994001125A1/fr not_active Application Discontinuation
- 1993-07-09 EP EP93917072A patent/EP0627930A4/fr not_active Withdrawn
- 1993-07-09 AU AU46711/93A patent/AU4671193A/en not_active Abandoned
- 1993-07-13 MX MX9304209A patent/MX9304209A/es active IP Right Grant
- 1993-07-13 ZA ZA935055A patent/ZA935055B/xx unknown
- 1993-07-13 CN CN93116777A patent/CN1087829A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0357571A2 (fr) * | 1988-06-10 | 1990-03-07 | Medivir Aktiebolag | Pyrimidine-nucléosides |
WO1993005806A1 (fr) * | 1991-09-13 | 1993-04-01 | Alpha 1 Biomedicals, Inc. | Composition et procede pour le traitement de l'hepatite c |
WO1996000573A1 (fr) * | 1994-06-30 | 1996-01-11 | Bio-Logic Research And Development Corporation | Compositions pour stimuler la fonction immunitaire |
Non-Patent Citations (1)
Title |
---|
See also references of WO9401125A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1994001125A1 (fr) | 1994-01-20 |
CN1087829A (zh) | 1994-06-15 |
AU4671193A (en) | 1994-01-31 |
EP0627930A1 (fr) | 1994-12-14 |
ZA935055B (en) | 1995-04-13 |
MX9304209A (es) | 1994-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA947354B (en) | Composition and process for treating metal | |
AP9300598A0 (en) | Compositions and method for waste treatment | |
EP0717592A4 (fr) | Procede et composition de traitement du syndrome d'apathie-amotivation | |
ZA949346B (en) | Composition and process for treating metal | |
EP0556447A3 (en) | Surfactant composition and method of making the same | |
EP0579453A3 (fr) | Composition pour le traitement de maçonnerie et procédé. | |
EP0627930A4 (fr) | Composition et procede de traitement de l'hepatite b. | |
ZA931778B (en) | Method and composition for the treatment of osteoporosis | |
ZA948252B (en) | Method and composition for treatment of autoimmune hepatitis | |
GB9014307D0 (en) | Method of treatment and compositions therefor | |
ZA932483B (en) | Method and composition for treating acne | |
AU9087591A (en) | Composition and method for treating metal | |
GB9224295D0 (en) | Method and composition | |
EP0454169A3 (en) | Photomask and method of treating the same | |
GB9202196D0 (en) | Method of treatment | |
EP0611214A3 (fr) | Composition acide et procédé d'utilisation. | |
EP0717622A4 (fr) | Procedes de traitement du vih au moyen d'azaspiranes | |
ZA939171B (en) | Composition and process for treating tinplate | |
SG54220A1 (en) | Composition and process for treating metal | |
CS61691A2 (en) | Composition for dung-water treatment and method of dung-water treatment | |
AU5467198A (en) | Composition and method of treating hepatitis B | |
GB9026896D0 (en) | Method and composition | |
GB9201391D0 (en) | Method of treatment | |
PL289358A1 (en) | Posticide and method of treating soil therewith | |
GB9211591D0 (en) | Method and composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970703 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 19940927 |
|
17Q | First examination report despatched |
Effective date: 19980401 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990223 |